Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129132) titled 'Observation of the effect of esketamine rapid antidepressant in patients with different ages' on July 31.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Changzhou Second People's Hospital
Condition:
Depression disorder
Intervention:
Adolescent group:Esketamine 0.2mg/kg was infused by a peripheral intravenous pump
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-11-08
Target Sample Size: Adolescent group:250;The middle and elderly group:250;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...